Evidence map›Paper›PMID 37237730›Full record

ArticleAntibiotics (Basel, Switzerland)2023

Ongoing Strategies to Improve Antimicrobial Utilization in Hospitals across the Middle East and North Africa (MENA): Findings and Implications.

Abdul Haseeb, Zikria Saleem, Aseel Fayk Maqadmi, Roaa Abdulrahman Allehyani, Ahmad J Mahrous, Mahmoud E Elrggal, Sairah Hafeez Kamran, Manal AlGethamy, Asem Saleh Naji, Abdullmoin AlQarni and 11 more

Abstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Molecular epidemiology of methicillin-resistantFrontiers in microbiology · 2025
    Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Abdul HaseebDepartment of Clinical Pharmacy, College of Pharmacy, Umm Al-Qura University, Makkah 24382, Saudi Arabia.ORCID 0000-0003-2455-5054
Zikria SaleemDepartment of Pharmacy Practice, Faculty of Pharmacy, Bahauddin Zakariya University, Multan 60800, Pakistan.ORCID 0000-0003-3202-6347
Aseel Fayk MaqadmiDepartment of Clinical Pharmacy, College of Pharmacy, Umm Al-Qura University, Makkah 24382, Saudi Arabia.
Roaa Abdulrahman AllehyaniDepartment of Clinical Pharmacy, College of Pharmacy, Umm Al-Qura University, Makkah 24382, Saudi Arabia.
Ahmad J MahrousDepartment of Clinical Pharmacy, College of Pharmacy, Umm Al-Qura University, Makkah 24382, Saudi Arabia.ORCID 0000-0002-7140-741X
Mahmoud E ElrggalDepartment of Clinical Pharmacy, College of Pharmacy, Umm Al-Qura University, Makkah 24382, Saudi Arabia.
Sairah Hafeez KamranInstitute of Pharmacy, Lahore College for Women University, Lahore 54000, Pakistan.
Manal AlGethamyDepartment of Infection Prevention and Control Program, Alnoor Specialist Hospital, Makkah 24241, Saudi Arabia.
Asem Saleh NajiInfectious Diseases Department, Alnoor Specialist Hospital, Makkah 24241, Saudi Arabia.
Abdullmoin AlQarniInfectious Diseases Department, Alnoor Specialist Hospital, Makkah 24241, Saudi Arabia.
Khalid W AlhariqiInfectious Diseases Department, Alnoor Specialist Hospital, Makkah 24241, Saudi Arabia.
Muhammad Arslan KhanThe Indus Hospital, Bedian Road, Lahore 54000, Pakistan.
Kiran IbrahimPrimary and Secondary Healthcare Department, DHQ Hospital Khushab, Khushab 41200, Pakistan.
Fahad RaeesDepartment of Medical Microbiology, Faculty of Medicine, Umm Al-Qura University, Makkah 24382, Saudi Arabia.
Aisha AzmatDepartment of Physiology, Faculty of Medicine, Umm Al-Qura University, Makkah 24382, Saudi Arabia.
Aislinn CookCentre for Neonatal and Paediatric Infection, St. George's University of London, London SW17 0RE, UK.ORCID 0000-0002-9189-7815
Stephen M CampbellCentre for Epidemiology and Public Health, School of Health Sciences, University of Manchester, Manchester M13 9PL, UK.ORCID 0000-0002-2328-4136
Giulia LorenzettiCentre for Neonatal and Paediatric Infection, St. George's University of London, London SW17 0RE, UK.ORCID 0000-0001-9270-0917
Johanna C MeyerSchool of Pharmacy, Sefako Makgatho Health Sciences University, Ga-Rankuwa, Pretoria 0208, South Africa.ORCID 0000-0003-0462-5713
Brian GodmanSchool of Pharmacy, Sefako Makgatho Health Sciences University, Ga-Rankuwa, Pretoria 0208, South Africa.ORCID 0000-0001-6539-6972
Catrin E MooreCentre for Neonatal and Paediatric Infection, St. George's University of London, London SW17 0RE, UK.ORCID 0000-0002-8639-9846

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antimicrobial resistance (AMR) is an increasing global concern, increasing costs, morbidity, and mortality. National action plans (NAPs) to minimize AMR are one of several global and national initiatives to slow down rising AMR rates. NAPs are also helping key stakeholders understand current antimicrobial utilization patterns and resistance rates. The Middle East is no exception, with high AMR rates. Antibiotic point prevalence surveys (PPS) provide a better understanding of existing antimicrobial consumption trends in hospitals and assist with the subsequent implementation of antimicrobial stewardship programs (ASPs). These are important NAP activities. We examined current hospital consumption trends across the Middle East along with documented ASPs. A narrative assessment of 24 PPS studies in the region found that, on average, more than 50% of in-patients received antibiotics, with Jordan having the highest rate of 98.1%. Published studies ranged in size from a single to 18 hospitals. The most prescribed antibiotics were ceftriaxone, metronidazole, and penicillin. In addition, significant postoperative antibiotic prescribing lasting up to five days or longer was common to avoid surgical site infections. These findings have resulted in a variety of suggested short-, medium-, and long-term actions among key stakeholders, including governments and healthcare workers, to improve and sustain future antibiotic prescribing in order to decrease AMR throughout the Middle East.

Indexed as

antimicrobial resistanceantimicrobialsantimicrobial stewardship programsMiddle Eastquality indicatorsstrategiessurgical site infectionsutilization patterns

Identifiers

PMID37237730
PMCPMC10215537

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.